Definition and impact of SRO listed companies: https://www.investopedia.com/terms/s/sro.asp b. Arrayit reports $155,000 microarray platform RFQ from the United States Food and Drug Administration FDA c. 1-2-18: Arrayit completes site visit and laboratory tour with a key business-to-business B2B partner and regulatory consultant regarding submission of a proprietary microarray product line to the United States Food and Drug Administration for FDA clearance https://www.fda.gov d. 3-14-18: Arrayit clinical team submits requested standard operating procedures SOPs and other documentation required for submission of a major microarray technology product to the United States Food and Drug Administration FDA for FDA regulatory clearance https://www.fda.gov e. 4-30-18: Arrayit government contracts team quotes $76,500 microarray life sciences instrument sale to a top official at the United States Food and Drug Administration FDA headquartered in Silver Spring Maryland and ensuring the safety of the nation's food and drugs https://www.fda.gov f. 5-17-18: Arrayit clinical team confirms meeting with the United States Food and Drug Administration FDA to discuss FDA clearance of a major product line. The FDA is headquartered in Silver Spring Maryland USA and improves healthcare by ensuring public safety https://www.fda.gov g. 6-19-18: Arrayit CLIA clinical team confirms July 2 2018 meeting with the United States Food and Drug Administration FDA to discuss FDA clearance of a major microarray product line. The FDA is HQ in Maryland USA and funded by a massive $4.9 billion annual budget https://www.fda.gov h. 6-27-18: Arrayit CLIA clinical team schedules 7/1 Sunday evening dinner meeting in advance of the 7/2 meeting with top officials at the United States Food and Drug Administration FDA HQ in Silver Spring Maryland USA and regulating $1 trillion+ in consumer products https://www.fda.gov i. 7-2-18: Arrayit CLIA clinical team meets with top brass at the United States Food and Drug Administration FDA to discuss FDA approval of a major product line. The FDA is headquartered in Silver Spring Maryland USA and oversees $1 trillion+ in consumer products https://www.fda.gov j. 7-3-18: Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval. k. 7-16-18: July 16, 2018 - Sunnyvale, CA - Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces the sale of clinical instrumentation to the United States Food and Drug Administration (FDA). Arrayit uses the same clinical instrumentation in its Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the Centers for Medicare and Medicaid Services (CMS) and the State of California Department of Public Health (CDPH). The instrumentation reads and reports test results for the company's allergy and dietary wellness tests and pipeline tests for ovarian cancer and Parkinson's Disease (PD). https://www.marketwatch.com/press-release/arrayit-corporation-reports-clinical-instrumentation-sale-to-the-united-states-food-and-drug-administration-2018-07-16?siteid=bigcharts&dist=bigcharts Award ID (Mod#): 75F40118P10123 ( 0 ) (View) Award Type: PURCHASE ORDER Vendor Name: ARRAYIT CORPORATION Contracting Agency: FOOD AND DRUG ADMINISTRATION Date Signed: July 09, 2018 Action Obligation: $43,380 Referenced IDV: Contracting Office: FDA OFFICE OF ACQ GRANT SVCS NAICS (Code): ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING ( 334516 ) PSC (Code): LABORATORY EQUIPMENT AND SUPPLIES ( 6640 ) Vendor City: SUNNYVALE Vendor DUNS: 962379470 Vendor State: CA Vendor ZIP: 940854518 Global Vendor Name: ARRAYIT CORPORATION Global DUNS Number: 962379470 https://www.usaspending.gov/#/award/67069919 l. 9-24-18: Arrayit new GlobeNewswire press release "Arrayit Corporation Ships Clinical Instrumentation and Software to the United States Food and Drug Administration" is important because it empowers top FDA scientists with the same technology we use in our CLIA lab https://finance.yahoo.com/news/arrayit-corporation-ships-clinical-instrumentation-093000351.html … m. 12-20-18: Arrayit web team adds most recent 12/17/2018 GlobeNewswire press "Arrayit Corporation Fulfills Clinical Instrumentation Contract with the United States Food and Drug Administration" to the home, corporate and investor pages for shareholder convenience http://arrayit.com/index.html n. 2-21-19: Arrayit accounting department reports $43,000 clinical instrumentation payment from the top United States Food and Drug Administration FDA HQ in Silver Spring Maryland USA and ensuring consumer safety by reviewing $1 trillion+ consumer healthcare products https://www.fda.gov o. 4-30-19: Arrayit sales and marketing team reports $190,400 contractor sourcing request from the prestigious United States Food and Drug Administration FDA HQ in Silver Spring Maryland USA and regulating clinical products totaling $1 trillion in annual revenues https://www.fda.gov p. 5-17-19:Arrayit sales and marketing team quotes $495,140 microarray life sciences services sale to the prestigious United States Food and Drug Administration FDA headquartered in Silver Spring Maryland USA and ensuring the safety of $1 trillion consumer products https://www.fda.gov q. 5-21-19: Arrayit clinical sales team quotes $228,580 clinical testing services sale to the prestigious United States Food and Drug Administration FDA headquartered Silver Spring Maryland USA and regulating medical products with annual revenues topping $1 trillion https://www.fda.gov r. 5-23-19: Arrayit clinical sales team quotes $3,808,000 clinical testing services sale to the world renowned United States Food and Drug Administration FDA HQ in Silver Spring Maryland USA and ensuring consumer product safety topping $1 trillion in annual revenues http://arrayit.com/Clinical/Allergy_Test/allergy_test.html …
2. ALLERGY TESTING: Arrayit offers allergy testing through an increasing number of market sub-brands. Fingerstick Allergy Program Overview
Arrayit web team adds updates to our allergy testing web page including electronic portal access for doctors and clinics wishing to utilize our finger stick microarray test for allergy testing and our suite of immunotherapy products for allergy treatment (link: http://arrayit.com/Clinical/Allergy_Test/allergy_test.html) arrayit.com/Clinical/Aller…
“On a sample of 17,000 tests there were zero false negatives. Skin testing has average 30% false negatives. Its proven to be more sensitive than Immunocap. In fact its so sensitive that it often detects allergic reaction to things for which the patient has no symptoms.. We have several thousand people on immunotherapy from the blood test results – Ive heard no complaints.” Michael Berg Every Ancillary
a. AllergyGo/AllergyPro & Arrayit partnership:
“The services on this website are provided by ARRAYIT CORPORATION, a Nevada corporation (“Arrayit”) and ALLERGYGO, LLC, a Texas limited liability company (“AllergyGo”). Arrayit is in the business of developing and manufacturing certain proprietary life science technologies for disease prevention and treatment, specifically including advanced blood card technology with IgE microarray testing for allergens (“Tests”), and AllergyGo is in the business of marketing and distributing allergy testing products.” http://allergygo.com/
AllergyPro is the only company to use the same proteins for blood testing, scratch testing and immunotherapy in the world.
Same oral allergy toothpaste that is mentioned as “coming soon” in the PFDAllergy/AllergyPro website? https://allovate.com/
Allergy121 another market sub-brand?
Arrayit Allergy121 finger stick allergy test measures IgE reactivity to penicillin providing a useful indication for penicillin allergy. Arrayit CLIA clinical team strongly endorses National Penicillin Allergy Day on September 28 2018 to raise awareness (link: https://nationalpenicillinallergyday.com) nationalpenicillinallergyday.com
AllergyPro & LabPharm partnership: Due to this partnership, Labpharm will be able to offer Top Level %’s. We will be working with a limited number of distribution groups on this product.
We are proud to announce that our companies, Allergy Labs of America and LabPharm, have entered into a strategic partnership with AllergyPro! The AllergyPro platform brings us a new proprietary finger stick blood-drop allergy cards are Exclusive to AllergyPro! This option has ZERO COST for the clinicians, and is billed through our IN-NETWORK lab partner!
Instead of the customary full blood draw on a patient, your physicians will be able to perform a “finger stick” and require only a few drops of blood on the allergy card to test for Inhalant and Non-Inhalant Allergies! This same card is then sent off and processed through our exclusive, IN-NETWORK Lab Partner! AllergyPro is the Allergy solution for Providers, meaning their simple, affordable, safe, and effective solution can be used by a broad range of practitioners (i.e. pediatrics, urgent care, dermatology, gastroenterology, pulmonology, OBGYN, and small volume family practices).
We are very excited to have united the Allergy Labs of America and AllergyPro models to be able to offer a comprehensive allergy solution for your providers throughout the country. This new partnership affords your doctors a wide range of allergy solutions that can only be found at LabPharm!
* Listen to the LabPharm conference call folks. Skip to 28:00-30:00, which talks about one of Arrayit’s market sub-brands... AllergyPro.
For over 10 years, Allergy Labs of America has specialized specifically in the Allergy Testing and Treatment services. ALA is an Ancillary service company offered from our parent company LabPharm LLC. LabPharm has over 50,000 physicians currently utilizing services offered. ALA Works with a vast network of these clinics to provide a gold standard of healthcare to patients, promote higher education, and innovation within our field.
LabPharm/Allergy Labs of America contract http://www.labpharmllc.com/marketingmaterial/allergypresentation(RS).pdf In around 2017 looks like a partnership with Healthy Plus happened. Healthy Plus integrated with Athenahealth network in late 2017. Athenahealth currently has more than 114,000 providers and 110 million patients.
By using this particular kind of test, our lab can thoroughly measure the IgG antibody levels against the proteins of over 200 different foods. This progressive technique works to identify the foods that respond negatively with your system–all with just a few drops of blood dispensed by a basic finger prick.
5-3-18: Arrayit business development team expands sales and marketing agreement with food sensitivity testing leader Pinnertest headquartered in North Bergen New Jersey USA and improving well-being by harmonizing diet and genetics through personalized proteomics https://pinnertest.com
5-13-18: Arrayit releases new company newsletter featuring our dynamic business-to-business B2B product Pinnertest which is the market's finest consumer test for dietary wellness and food intolerance based finger stick and advanced microarray testing of 202 foods https://pinnertest.com
6-1-18: Arrayit CLIA clinical and bioinformatics teams begin implementation of additional software automation to increase test throughput for our physician-ordered business-to-business Pinner USA blockbuster lifestyle test Pinnertest for greater dietary wellness
c. Spiriplex is one of Arrayit’s allergy marketing partners.
https://spiriplex.com Here’s an email from Dr Mark Schena: ‘The financials will be the 10-Ks for 2014-2017 and the 10-Qs for the first three quarters of 2018. Spiriplex is one of our allergy marketing partners. Thanks, Mark ‘
Spiriplex Patent: Method and device for allergy testing and treatment.
“Aspects of the inventions described herein have been described on the website of ARRAYIT® Corporation (arrayit.com) and links thereon. All such disclosures were made by another who obtained the subject matter disclosed directly or indirectly from the inventor of the present application.”
The company is further waiting on FDA approval and an NIH clinical trials update is due this month (February).
Sponsor is United Allergy Services The Encore Holdings & Spiriplex partnership is huge. Encore Holdings is averaging about 2-3 new hospital partnerships a month. Encore Holdings is a national hospital marketing company. They are taking work from LabCorp & Quest & helping these hospitals bring in a substantial increase in revenues. The sales representatives involved are getting their foot in the door by introducing the allergy test.
Methods of applying proteins to surfaces to form arrays are well known. The immobilization may be covalent or noncovalent, via a linker moiety, or tethering to an immobilized moiety. These methods are well known in the field of solid phase synthesis and micro-arrays, for example as described in Beier et al., Nucleic Acids Res. 27:1970-1-977 (1999), and U.S. Pat. No. 6,101,946 to Martinsky. Examples include binding moieties for attaching proteinaceous molecules to a solid support include streptavidin or avidin/biotin linkages, carbamate linkages, ester linkages, amide, thiolester, (N)-functionalized thiourea, functionalized maleimide, amino, disulfide, amide, hydrazone linkages, and among others. Furthermore, a number of companies offer commercial services for preparing protein arrays, for example Arrayit Corporation (Sunnyvale, Calif.). Preferably, the source of the proteins is an extract of the allergen source, such as those available from GREER® Allergy Immunotherapy (Lenoir, N.C.). Preferably, the extract of the allergen source is standardized.
Aspects of the inventions described herein have been described on the website of ARRAYIT® Corporation (arrayit.com) and links thereon. All such disclosures were made by another who obtained the subject matter disclosed directly or indirectly from the inventor of the present application.
1-2-18: Arrayit completes site visit and laboratory tour with a key business-to-business B2B partner and regulatory consultant regarding submission of a proprietary microarray product line to the United States Food and Drug Administration for FDA clearance https://www.fda.gov
1-3-18 Arrayit advanced microarray technology to be incorporated into a clinical trial by a major pharmaceutical giant in a development that could significantly increase revenues and earnings in 2018 arrayit.com/Products/products.html
f. Foreign markets (some examples): 6-15-18: Arrayit CLIA clinical laboratory and Pinner USA expand Pinnertest dietary wellness food intolerance testing to a top clinical laboratory headquartered in Hong Kong and serving the lucrative and rapidly expanding wellness testing markets in South China https://pinnertest.com 8-29-18: Arrayit CLIA clinical team reports finger stick allergy testing commercialization opportunity with a leading healthcare provider headquartered in Jeddah Saudi Arabia and serving the massive high-growth $20 billion Saudi Arabian health and wellness markets http://arrayit.com/Clinical/clinical.html … 9-10-18: Arrayit business development team signs non-disclosure agreement with the global head of business development and mergers and acquisitions of a major allergy testing company headquartered in the European Union and advancing allergy healthcare globally http://arrayit.com/Clinical/clinical.html … 6-21-19: Arrayit business development team reports allergy testing services growth opportunity with a healthcare import leader HQ in Bangalore India and serving the rapidly expanding India healthcare markets projected at $372 billion annually by The Economic Times https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/indian-healthcare-market-to-hit-372-bn-by-2022/articleshow/61903998.cms …
Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the FDA regarding approval of a major product line, signed allergy testing contracts with more than 300 medical clinics, received approval for in-store promotions by a major retailer, announced allergy testing partnerships with major allergy therapeutics providers, received approval for direct Medicare billing by CMS, launched the Patient Data Solutions allergy portal for doctors and clinics, celebrated 25 years of company operations, and announced an allergy testing services agreement with a major health and wellness provider. Fulfilling the FDA clinical instrumentation contract strengthens the company’s relationship with the agency that ensures the safety of medical devices and pharmaceutical consumer healthcare products exceeding $1,000,000,000,000 ($1 trillion) in annual revenues.
“The retail chain, which reports revenues exceeding $50,000,000,000 ($50 billion US dollars) annually, has more than 2,000 locations nationwide.”
The Kroger Co. operates nearly 2,200 retail Pharmacies in 37 states, each staffed with caring professionals dedicated to helping people lead healthier lives.
In 2017, Kroger generated 62.38 billion U.S. dollars with non-perishable items. Kroger is a supermarket chain operating in the United States.
4. Kaiser Permanente a. 5-11-18: Arrayit prototyping team completes custom whole blood collection card for $64.6 billion health maintenance organization HMO leader Kaiser Permanente headquartered in Oakland California USA and providing premium healthcare to 11,700,000 members in 8 states https://healthy.kaiserpermanente.org b. 5-25-18: Arrayit CLIA clinical team completes allergy testing sample collection kits for health maintenance organization (HMO) giant Kaiser Permanente headquartered in Oakland California USA and providing premium healthcare for 11.7 million health plan members (link: https://healthy.kaiserpermanente.org) healthy.kaiserpermanente.org c. 5-31-18: Arrayit CLIA clinical team schedules follow up visit regarding allergy testing with the world's largest health maintenance organization HMO Kaiser Permanente headquartered in Oakland California USA and providing premium healthcare to 11,100,000 patients https://healthy.kaiserpermanente.org d. 6-4-18: Arrayit CLIA clinical team announces technology evaluation including finger stick sampling, blood card collection and microarray wellness testing for allergy and asthma by world healthcare leader Kaiser Permanente headquartered in Oakland California USA https://healthy.kaiserpermanente.org e. 6-14-18: Arrayit CLIA clinical team submits Client Services Manual to $64.6 billion health maintenance organization HMO leader Kaiser Permanente headquartered in Oakland California USA and providing premium healthcare services and care for 11.7 million patients https://healthy.kaiserpermanente.org f. 10-24-18: Arrayit CLIA clinical team reports scheduled sales visit today to present finger allergy microarray testing to top officials at prestigious Kaiser Permanente headquartered in Oakland California USA and providing premium healthcare to 11.7 million members https://healthy.kaiserpermanente.org g. 2-1-19: Arrayit clinical sales team announces enrollment of Kaiser Permanente in our Patient Data Solutions allergy testing portal providing on-line test kits, test reports and immunotherapy options for allergy and asthma doctors in one of the nation's top HMOs https://www.patientdatasolutions.com/signup/rs4884/ h. 3-14-19: Arrayit clinical services team commences finger stick allergy testing for a major health maintenance organization HMO HQ in the United States and providing premium healthcare benefits to more than 10 million Americans on annual revenues topping $70 billion (link: http://arrayit.com/Clinical/Allergy_Test/allergy_test.html) arrayit.com/Clinical/Aller… Kaiser: “12.2 million insured members, 39 hospitals, $72.7 billion in annual revenues” https://nonprofitquarterly.org/2019/01/18/kaiser-makes-first-investments-from-200-million-affordable-housing-fund/
1/16/2019: Arrayit receives company profile invitation in upcoming edition “The Companies with Most Innovative Nanotechnology Solutions” by corporate business solutions leader Insights Success providing actionable intelligence on the world's leading public companies (link: https://www.insightssuccess.com) insightssuccess.com
“Microsoft inks a Huge Deal with Walgreens Boots Alliance”
1/29/2019: Arrayit clinical sales team completes custom Client Services Manual for retail pharmacy and healthcare clinic leader Walgreens headquartered in Deerfield Illinois USA and serving 5.9 million American customers daily on annual revenues of $131.5 billion (link: https://www.walgreens.com/topic/pharmacy/healthcare-clinic.jsp) walgreens.com/topic/pharmacy…
TeleHealth: “Order your home IgE allergy test kit today. Just four drops of blood from a single finger stick – no phlebotomy, no lab visits, no doctor appointments. After testing is complete, results are available to view online, followed by a video chat with a physician (not available in all areas). AllergyGenius is the most convenient and simple allergy testing kit available.”
CNBC has learned that a secretive team within Apple’s growing health unit has been in talks with developers, hospitals and other industry groups about bringing clinical data, such as detailed lab results and allergy lists, to the iPhone, according to a half-dozen people familiar with the team. And from there, users could choose to share it with third parties, like hospitals and health developers.
After many months of rumors, Apple announced that it is launching a personal health record (PHR) feature with iOS 11.3, the beta of which launched Wednesday to users in Apple's iOS Developer Program. The feature, called Health Records, will aggregate existing patient-generated data in the Health app with data from a user's electronic medical record — if the user is a patient at a participating hospital. At launch, Apple is working with 12 hospitals across the country, including Penn Medicine, Cedars-Sinai in Los Angeles, Johns Hopkins, and Geisinger Health System.
Arrayit's current TeleHealth services available through its marketing partner:
“Order your home IgE allergy test kit today. Just four drops of blood from a single finger stick – no phlebotomy, no lab visits, no doctor appointments. After testing is complete, results are available to view online, followed by a video chat with a physician (not available in all areas). AllergyGenius is the most convenient and simple allergy testing kit available.”
At the end of 2017, Healthy Plus (who markets Arrayit’s finger stick sub-brand Allergenex) announced a newly integrated application for Athenahealth's growing healthcare provider network. Athenahealth currently has more than 114,000 providers and 110 million patients.
Are there even ties between Healthy Plus & Aetna (see the joint benefit plan below)? Aetna also has a partnership with Apple Inc and CVS Health has plans to acquire Aetna.
3-26-19: Sunnyvale, March 25, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, is working closely with an Apple enterprise healthcare partner to increase revenues and earnings for fiscal year 2019 (FY2019). This new partnership leverages the widely used Apple iPad platform and iPhone operating system (iOS) to streamline key aspects of Arrayit doctor-prescribed allergy testing services including patient scheduling, test kit ordering, electronic retrieval of test results and requests for ancillary treatment options, all in manner this is fully compliant with the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Arrayit's convenient finger stick testing services are being increasingly utilized by doctors to detect, manage and treat allergy and asthma, which impact approximately 60 million Americans annually. 3-27-19: Arrayit Apple enterprise healthcare partner software solutions for physician-prescribed allergy testing services available to 1.1 million doctors in the United States to more effectively identify, treat and manage allergy and asthma in 60 million Americans http://arrayit.com/Clinical/Allergy_Test/allergy_test.html … 5-21-19: Arrayit Apple Enterprise Healthcare Partner's utilization of Artificial Intelligence is facilitating our physician-ordered allergy testing services in a growing trend towards using computers to improve healthcare outcomes per news leader Digital Trends https://www.digitaltrends.com/computing/ai-driven-medicine-nvidia-gtc-2019/ … https://www.apple.com/healthcare/health-records/
7. Other large pharmacy chains including CVS (+walmart?) 1-9-19: Arrayit clinical sales team conducts sales visit this morning at a top health maintenance organization HMO in Northern California to offer our innovative and convenient finger stick microarray allergy test to their 10 million+ health plan patient members http://arrayit.com/Clinical/Allergy_Test/allergy_test.html … 1-10-19: Arrayit clinical sales team completes sales visit this week at a top health maintenance organization HMO in Northern California offering our non-invasive and convenient finger stick microarray allergy test to their 10 million+ health plan patient members http://arrayit.com/Clinical/clinical.html … 1-17-19: Arrayit clinical sales team reports $15,000 clinical sale of our non-invasive finger stick health and wellness testing services to a leading healthcare company providing premium healthcare to millions of Americans daily on annual revenues exceeding $50B http://arrayit.com/Clinical/clinical.html … 1-23-19: Arrayit clinical sales team prepares doctor-prescribed finger stick allergy test marketing presentation for a leading retail pharmacy chain headquartered in the United States and serving millions of customers daily on annual revenue exceeding $20 billion http://arrayit.com/Clinical/clinical.html … 1-25-19: Arrayit clinical sales team completes private branded finger stick allergy testing services information for a leading pharmacy retailer headquartered in the United States and serving millions of customers daily on annual revenues exceeding $20 billion http://arrayit.com/Clinical/Allergy_Test/allergy_test.html … Arrayit clinical sales team reports $1,600 finger stick allergy testing sale to a top healthcare company headquartered in the United States and providing premium healthcare services to tens of millions Americans on revenues exceeding $60 billion annually https://t.co/TRfj3lWfRd
Aetna revenues appx 60.5B And guess who owns Aetna as of Dec 2017? CVS
Arrayit clinical sales team reports finger stick allergy testing services sale to a leading healthcare company headquartered in the United States and providing premium healthcare to tens of millions Americans on revenues exceeding $90 billion per year https://t.co/TRfj3lWfRd
Anthem revenues appx 89B 1-24-19: Arrayit clinical sales team reports finger stick allergy testing expansion opportunity with a top life sciences leader headquartered in the Southern United States and commercializing doctor-ordered tests for the massive $3 trillion US healthcare markets http://arrayit.com/Clinical/Allergy_Test/allergy_test.html … 2-1-19: Arrayit clinical sales team reports doctor-prescribed microarray testing services sale to a leading healthcare company headquartered in the United States and providing healthcare to tens of millions of Americans on revenues exceeding $50 billion annually https://t.co/TRfj3lWfRd 2-8-19: Arrayit production team completes $38,500 microarray manufacturing run to build inventory for a leading biotechnology company HQ in the Northeastern USA and commercializing doctor-prescribed finger stick tests for the massive health and wellness markets http://arrayit.com/Clinical/clinical.html … 2-9-19: Arrayit clinical sales team reports $25,300 clinical finger stick testing sale to a leading healthcare company headquartered in the United States and providing premium healthcare services to millions of Americans on revenues exceeding $80 billion annually http://arrayit.com/Clinical/clinical.html … 2-12-19: 2-12-19: Arrayit production team completes $96,250 clinical microarray manufacturing run to build inventory for a leading biotechnology company headquartered in the Northeastern USA and commercializing finger stick tests for the massive health and wellness markets http://arrayit.com/Clinical/clinical.html … 2-13-19: Arrayit clinical sales team reports $2.5 million allergy testing services sales lead from a major allergy testing company HQ in the Southeastern USA and providing allergy testing and treatment for customers in the massive $3 trillion healthcare markets http://arrayit.com/Clinical/Allergy_Test/allergy_test.html … 3-28-19: Arrayit clinical sales team reports $2,000,000 clinical testing services sales to leading health benefits payers providing premium government and commercial healthcare coverage to 100 million+ Americans in the massive $3 trillion US healthcare markets http://arrayit.com/Clinical/Allergy_Test/allergy_test.html … CVS: https://cvshealth.com/about/facts-and-company-information
“Arrayit sold 2,000,000 testing services to CVS today. That is huge $$$!"
"5 million customers a day times 365 equals 1.8 billion a year, $131billion in revenue” 3-28-19: Arrayit clinical sales team reports finger stick allergy testing services evaluation by a top retail pharmacy chain headquartered in the United States and completing 1.8 billion American customer visits per year on annual revenues exceeding $100 billion http://arrayit.com/Clinical/Allergy_Test/allergy_test.html … 4-3-19: Arrayit business development team reports revenues and earnings growth opportunity with a top retail distribution leader headquartered in Fort Lauderdale Florida USA with established retail connections to healthcare leaders CVS, Walgreens and Walmart http://arrayit.com/Clinical/Allergy_Test/allergy_test.html …
7-10-19: Arrayit sales and marketing team reports $576,000 clinical services sales request from healthcare leader Ngee Ann Polytechnic headquartered Singapore and serving the lucrative high-growth consumer healthcare and lifestyle testing markets in Southeast Asia https://www.np.edu.sg/hs/Pages/default.aspx …
8. Veterinary diagnostics market: Arrayit reports positive steps towards entering the rapidly growing $6.7 billion veterinary diagnostics market with companion animal wellness tests that leverage our patented and proprietary microarray technology petproductnews.com/News/Veterinar. “Paw stick” product for animal companion testing: http://www.arrayit.com/Products/Protein_Microarrays/Pet_Allergy_Testing/pet_allergy_testing.html Now... There is a safe and painless way to test your animals for their allergies!
http://www.arrayit.com/Products/Protein_Microarrays/Pet_Allergy_Testing/pet_allergy_testing.html Here is a new link posted on today’s date, June 1, 2019: http://www.imagezap.co/cat-food-allergy-blood-test/ d. 2-20-18: Arrayit sales and marketing team reports $10,000 microarray services sale to a leading veterinary medicine company headquartered in the USA and focusing on companion diagnostic testing for the pet market http://arrayit.com/Services/services.html … e. 6-28-18: Arrayit CLIA clinical team accelerates microarray testing commercialization program with a top biologics provider to address the global pet care markets worth an estimated $202.6 billion annually by 2025 according to top market analysts Grand View Research https://www.prnewswire.com/news-releases/pet-care-market-size-worth-2026-billion-by-2025--cagr-49-grand-view-research-inc-680523541.html … f. 7-25-18: Manufacturing microarrays for an IgE blood test for dogs. Expanding the use of our technology into vetertinary clinics! g. 7-26-18: Arrayit CLIA clinical team completes $191,950 canine allergy microarray overnight manufacturing run to commercialize a dog allergy test for the high-growth lucrative $140 billion per year United States companion animal pet food and veterinary care markets https://t.co/TRfj3lWfRdhttps://t.co/xroJTs4NVR h. 8-2-18: Arrayit veterinary medicine team demonstrates quantitative immunoglobulin E (IgE) measurements for food and environmental allergy testing in canines to advance commercialization of a dog allergy test for the massive $42 billion US veterinary health market https://www.ibisworld.com/industry-trends/market-research-reports/professional-scientific-technical-services/professional-scientific-technical-services/veterinary-services.html … i. 8-23-18: Arrayit CLIA clinical laboratory staff and senior management report strategic planning and commercialization conference call this morning with a world leader in veterinary medicine and healthcare http://arrayit.com/Clinical/clinical.html … j. 8-29-18: Arrayit senior management completes strategic business development conference call with a world leader in veterinary medicine to commercialize "paw stick" microarray tests for canine health and wellness in the rapidly expanding $40 billion US pet markets http://arrayit.com/Clinical/Allergy_Test/allergy_test.html … k. 9-12-18: Arrayit CLIA clinical team completes $10,000 allergy testing pilot validation study for a top veterinary healthcare company headquartered in the United States and serving the lucrative high-growth $25 billion companion animal and pet healthcare markets http://arrayit.com/Clinical/clinical.html … l. 10-2-18: Arrayit business development team reports microarray testing earnings and revenues expansion opportunity with a leading veterinary healthcare company headquartered in Chengdu China and serving the massive high growth lifestyle testing markets in East Asia http://arrayit.com/Clinical/clinical.html … m. 10-22-18: Arrayit CLIA clinical team provides pilot study statistical data analysis for a leading veterinary health company headquartered in the European Union and commercializing products for the lucrative high-growth companion animal healthcare testing markets http://arrayit.com/Clinical/clinical.html … n. 10-24-18: Arrayit sales and marketing department reports pro forma invoice to the prestigious Indian Veterinary Research Institute headquartered in Bangalore India and serving the lucrative high-growth $5.9 billion Asia-Pacific veterinary health and medicine markets http://ivri.nic.in o. 12-19-18: Arrayit business development team completes strategic investment conference call with a leading veterinary medicine firm regarding commercialization of a "paw" stick canine allergy test in the lucrative high-growth $25 billion veterinary healthcare market http://arrayit.com/Clinical/clinical.html … p. 7-12-19: Arrayit sales and marketing team reports $100,000 microarray life science platform request from a top veterinarian at the prestigious Laboratory of Veterinary Epidemiology headquartered in Warsaw Poland and advancing the forefronts of veterinary healthcare http://wmw.sggw.pl/en/departments/laboratory-of-veterinary-epidemiology-and-economics/ … q. https://optimumallergysolutions.com/animals r. https://www.lenusallergysolutiontesting.com/animals
LENUS ANIMAL ALLERGY SOLUTION TESTING SAFE - LAAST provides a lancet to draw only 5 drops of blood from the animal's ear or paw, minimizing discomfort and saving extensive amounts of time 9. Diabetes testing: a. http://shop.arrayit.com/diabetes.aspx b. Arrayit microarray services team accelerates biomarker discovery for growing $32 billion diabetes testing market prweb.com/releases/diabe c. 1-31-18: Arrayit clinical and microarray services teams reports positive project update from top diabetes research and companion diagnostic testing development leader headquartered in the Southern USA http://arrayit.com/Services/services.html … d. 6-29-18: Arrayit CLIA clinical team receives invitation to the 3rd World Congress on Clinical Trials in Diabetes being held on December 3-4 2018 in Vienna Austria and featuring the top experts in the $31.2 billion global diabetes testing and therapeutics markets http://www.wctd2018.com/default.aspx e. 9-28-18: Arrayit CLIA clinical team and a top diabetes research laboratory prepare a diabetes longitudinal study to evaluate the effectiveness of insulin treatment and microarray testing in a research patient cohort with symptomatic diabetic peripheral neuropathy http://arrayit.com/Clinical/clinical.html …
10. Parkinson’s Disease Test: The Parkinson’s Institute video link:
Arrayit has leveraged the company’s patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson’s Disease (PD). This important research project offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson’s Diagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.
Arrayit PDx™ Pre-Symptomatic Test for Parkinson’s Disease will be submitted to the United Sates Food and Drug Administration (FDA) as a 510(k) submission in the near future.
Arrayit Corporation and The Parkinson's Institute Research Collaboration
“This collaboration provides an important first step towards unraveling the mysteries of Parkinson's disease," stated Dr. Mark Schena, Ph.D., Arrayit President. "We look forward to working with The Parkinson's Institute to decipher the molecular basis of the disease," he continued. The Parkinson's Institute Assistant Professor Dr. Birgitt Schuele, M.D. added, "Parkinson's disease represents a serious and challenging medical condition. We are pleased to be deploying Arrayit technology to combat this illness.”
About The Institute WHO WE ARE The mission of The Parkinson’s Institute (The PI) is to provide comprehensive patient care, while discovering new treatment options to improve the quality of life for all Parkinson’s disease (PD) patients. As America’s only independent non-profit organization combining research and patient care for PD under one roof, we are committed to changing the landscape of movement disorder treatment and research. Since its founding, The PI has helped thousands of PD patients better manage their disease, developed new treatments for PD, and published groundbreaking research aimed to close the gap between science and practical care. By focusing on all three avenues of PD - cause, care and cure - The PI is a powerful force in PD research.
12. Ovarian cancer test (OvaDx): Arrayit Corporation has leveraged its proprietary life sciences platform to develop OvaDx®, the first definitive test for early stage detection of ovarian cancer. Arrayit also has pipeline diagnostic tests for Parkinson’s Disease, Plavix®, Male Fertility, and Prostate Cancer. These microarray-based tests will be available to the public upon FDA approval.
Doctors and nurses currently use 15 million CA-125 tests per year to monitor ovarian cancer, generating approximately $2 billion in worldwide revenue. Capturing 1% of the ovarian cancer monitoring market would generate $97.5 million in annual revenues for Arrayit through the manufacture and sale of 150,000 OvaDx® tests at $650 per test. Our Sunnyvale laboratories have more than adequate capacity to process 150,000 OvaDx® tests per year upon FDA approval. Dr Julie A. Taguchi at Arrayit headquarters announcing a sweet discovery? https://www.instagram.com/p/BgMsxken3yb/
From the Arrayit website:
Can ovarian cancer be cured by early stage detection and treatment?
Yes. According to Dr. Julie A. Taguchi, MD, of the Sansum Medical Clinic in Santa Barbara, CA, surgical removal of stage IA ovarian tumors effectively cures ovarian cancer in a large percentage of patients without the requirement for chemotherapy. According to the medical literature, the 20-year survival rate for stage IA patients is very good.
13. USDA: a. Arrayit and the United States Department of Agriculture Agricultural Research Service
Research Project: Molecular Identification and Characterization of Bacterial and Viral Pathogens Associated with Foods Location: Produce Safety and Microbiology Research
Approach: Objective 1: A fast, simple and high throughput array-based method for typing pathogens will be developed. Capture probes will be designed to target norovirus and hepatitis A virus, clinically-important Salmonella serovars and Campylobacter spp. To evaluate probe specificity, viral RNA or bacterial DNA will be extracted from clinical samples or cultured strains. A Cooperative Research and Development Agreement (CRADA) has been established with Arrayit Corporation to develop a fast, simple, and cost-effective test, in conjunction with inexpensive instrumentation.
b. https://www.twinarborlabs.com/ Third paragraph on the twin arbor touting Arrayit crada technology in use. More revenue streams! Cutting Edge Technology Twin Arbor Analytical utilizes cutting edge technologies such as Arrayit’s (ARYC) proprietary microarray platform. This system was developed as a research cooperative agreement with the United States Department of Agriculture – Agricultural Research Services (USDA-ARS) as a low-cost high throughput system for the analysis of microbial contaminants such as E. coli, salmonella, listeria, Noro virus and Hepatitis A.
c. https://www.mdpi.com/1424-8220/17/9/2157 d. http://www.arrayit.com/Arrayit_Corporation_ARYC_Corpo/Microarray_Media_-_Press/Arrayit_and_USDA_Expanding_Pat/arrayit_and_usda_expanding_patent_protection_for_food_safety_tes.html e. Arrayit-USDA food safety test readily detects Listeria monocytogenes implicated in recent food contamination recall freep.com/story/money/bu… f. Arrayit-USDA miniaturized and multiplexed food safety test can rapidly identify pathogens and increase food safety chicagotribune.com/business/ct-ch… g. Arrayit-USDA microarray technology food safety test Sensors manuscript published in Google Scholar database mdpi.com/1424-8220/17/9… h. Arrayit reports $228,000 microarray technology and services lead from top United States Department Agriculture USDA i. 1-9-18:Arrayit-USDA food safety team receives speaking invitation to the top international science meeting entitled the 22nd International Conference on Food Processing and Analysis to be held on October 11-13 2018 in Moscow Russia https://foodprocessing.foodtechconferences.org j. 2-12-18: Arrayit-USDA food safety testing team receives methods video publication invitation from research and science advancement leader JoVE headquartered in Cambridge Massachusetts USA and changing the way science is done https://www.jove.com k. 2-18-18: Arrayit-USDA Food Safety Microarray Test rapidly and accurately detects the strains of norovirus implicated in the 2018 Winter Olympics in PyeongChang South Korea http://www.foxnews.com/health/2018/02/16/what-is-norovirus-2018-winter-olympics-plagued-by-vomit-inducing-bug.html … l. Arrayit-USDA Food Safety Team receives publication invitation from Journal of Microbiology and Laboratory Science a top peer-reviewed scholarly journal dedicated to the advancement in all fields of microbiology and lab science http://www.scholarenajournals.com/journals/journal-of-microbiology-and-laboratory-science/jhome.php … m. Additional USDA Info: https://usdasearch.usda.gov/search?utf8=%E2%9C%93&affiliate=usda&query=arrayit&commit=Search n. 7-25-18: Arrayit government contracts team quotes $80,600 microarray life sciences services sale to the top government agency the United States Department of Agriculture USDA headquartered in Washington DC USA and funded by a massive $137,000,000,000 annual budget https://www.usda.gov o. 8-8-18: Arrayit government contracts team quotes $79,600 microarray life sciences services sale to the prestigious agricultural leaders United States Department of Agriculture USDA headquartered in Washington DC USA and funded by a massive $137 billion 2018 budget https://www.usda.gov
14. DOD (Blood Collection Cards): a. http://www.arrayit.com/Microarray_Diagnostics/Blood_Cards/blood_cards.htm b. Arrayit® Blood Card technology offers an advanced card-based whole blood collection method that collects, separates and stores whole blood components for research, veterinary and medical testing. Works great for protein microarray assays. Card design make it easy to ship sample through the mail at room temperature. c. https://m.youtube.com/watch?v=3qANkldK12U d. 5-13-15: Arrayit Corporation (OTCQB: ARYC) a life science technology leader, announces an agreement to supply custom Arrayit blood card technology to Vivos' Global Genome Vault, the only private human DNA vault on earth. https://finance.yahoo.com/news/arrayit-corporation-vivos-team-global-162100676.html e. Arrayit provides additional samples for $2.9 million microarray tech sale to United States Department of Defense DOD. http://www.defense.gov f. 4-18-16: Arrayit microarray technology team launches whole blood collection card research products. g. 8-31-16: Arrayit prepares bid for $4,500,000 blood card kit contract to US Department of Defense DOD https://t.co/0ePvq047Dy h. 3-16-17: Arrayit manufacturing team completes 800 whole blood card production run for the US Department of Defense. 15. ARMY:
a. Arrayit reports prostate cancer test sourcing request from United States Army Medical Center Bethesda Maryland usarmy.com b. Arrayit reports $1,745,000 microarray services inquiry from top government agency United States Army Medical Center c. Arrayit reports $84,000 microarray platform sale to http://US.Army ; Medical Research USAMRIID Frederick MD
16. National Institutes of Health: a. Arrayit FY2018 revenues and earnings may see positive impact from new $37.1 billion National Institutes of Health NIH budget boosting funding to biomedical research laboratories nationally for basic and targeted healthcare and precision medicine research (link: https://www.genomeweb.com/policy-legislation/congress-boosts-nih-funding-371b-new-spending-bill#.WrP67K2ZPOY) genomeweb.com/policy-legisla… b. Arrayit submits capabilities statement for major microarray services contract with National Institutes of Health NIH nih.gov c. 3-21-18: Arrayit sales and marketing team receives $1,050,000 genomics and proteomics pre-solicitation announcement from top government agency National Institutes of Health NIH headquartered in Bethesda Maryland USA and operating with a $31.3 billion annual budget https://www.nih.gov d. Arrayit government contract team reports $217,000 immunology-based microarray services inquiry from the world leading cancer research center National Cancer Institute NCI headquartered in Bethesda Maryland USA with a $5.3 billion annual operating budget cancer.gov e. Arrayit government contracts team reports $440,000 sample testing solicitation from the world leader Department of Health and Human Services National Cancer Institute NCI headquartered in Bethesda Maryland USA and supported by a $5.4 billion annual budget (link: https://www.cancer.gov) cancer.gov f. Arrayit government contracts team quotes $217,400 microarray services sale to the Department of Health and Human Services at the National Institutes of Health NIH headquartered in Bethesda Maryland USA and improving healthcare for the American people (link: https://www.nih.gov) nih.gov g. 8-17-18: Arrayit revenues and earnings may see positive impact from the new $45.5M National Institutes of Health NIH commitment to fund genome editing technology to improve human health. Arrayit technology enables powerful analysis of the human genome post editing https://www.genomeweb.com/research-funding/nih-commits-455m-fund-genome-editing-technology-projects#.W3bwTa2ZPOY … h. 2-14-19: Arrayit government contracts team submits laboratory capabilities statement for a $2.4 million biomedical research contract from the prestigious National institutes of Health NIH HQ in Bethesda Maryland USA and funded by a massive $34.7 billion 2019 budget https://www.nih.gov
17. Department of Veterans Affairs: a. Working closely with the VA(this is massive): https://optimumallergysolutions.com/va Thank you for your interest in our unique Allergy Test & Treatment Program which is the standard of care for The Department of Veterans Affairs.
b. 1-26-18: Arrayit government contracts team prepares molecular testing bid for the Department of Veteran Affairs Network Contracting Office NCO at the GV Sonny Montgomery VA Medical Center headquartered in Jackson Mississippi USA https://www.jackson.va.gov c. 3-13-18: Arrayit sales and marketing team reports request for information RFI and statement of work SOW for $126,000 microarray services contract from top government agency Department of Veterans Affairs headquartered in Fredericksburg Virginia USA https://www.va.gov d. 8-20-18: Arrayit CLIA clinical laboratory reports $2,490,000 clinical services sales request from the top government agency the United States Department of Veterans Affairs headquartered in Washington DC USA and providing premium healthcare services to our bravest https://www.va.gov e. 8-28-18: Arrayit shipping department ships $2,200 microarray life sciences consumables sale to healthcare leading Palo Alto Health Care System headquartered in Palo Alto California USA and providing advanced research and patient care for our cherished veterans https://www.paloalto.va.gov 18. CDC: Centers for Disease Control and Prevention: Just type in Arrayit or its CLIA number, which is 05D2147467. https://wwwn.cdc.gov/clia/Resources/LabSearch.aspx#SearchResultsTop a. 8-13-18: Arrayit sales and marketing team reports $43,000 microarray life sciences services sales request from the top government agency the Centers for Disease Control CDC HQ Atlanta Georgia USA and protecting the nation's health with a massive $11 billion budget https://www.cdc.gov b. 8-22-18: Arrayit sales and marketing team quotes $43,100 microarray life sciences services sale to a top scientist at the top government agency the Centers for Disease Control CDC headquartered in Atlanta Georgia USA and ensuring the public health of all Americans https://www.cdc.gov c. 9-12-18: Arrayit sales and marketing team reports $71,300 microarray life sciences sales request from the top government agency the Centers for Disease Control CDC headquartered in Atlanta Georgia USA and protecting and ensuring the health and safety of the nation https://www.cdc.gov
Our chemical trading subsidiary TeleChem International focuses on government contracts, specialty chemical sales and speciality chemical sourcing for our life sciences and healthcare segments. This is an important component of our company and we are pleased with their contribution.” a. 12-22-17: Arrayit chemical trading subsidiary TeleChem International Inc reports $8,100 speciality chemical sale to a top industrial supplier headquartered in Arlington Texas https://www.telecheminternational.com b. 1-23-18: Arrayit chemical trading subsidiary TeleChem International reports chemical synthesis inquiry from the National Center for Advancing Translational Sciences NCATS National Institutes of Health NIH for diagnostic and therapeutic methods and technologies https://ncats.nih.gov c. 2-2-18: Arrayit chemical trading subsidiary TeleChem International reports $25,000 specialty chemical sale to a top high-end specialty chemical company headquartered in the Western United States and focusing on advanced environmental remediation technology https://www.telecheminternational.com d. 2-23-18: Arrayit shipping department ships $25,000 specialty chemical sale for our chemical trading subsidiary TeleChem International to a leading environmental remediation company headquartered in the Western USA https://www.telecheminternational.com e. 3-19-18: Arrayit shipping department ships $16,200 specialty chemical sale to a chemical trading subsidiary TeleChem International customer and top supplier of advanced agricultural products Custom Ag Formulators headquartered in Fresno California USA http://www.customagformulators.com f. 6-13-18: Arrayit shipping department ships $9,000 specialty chemical sale on behalf of chemical trading subsidiary TeleChem International to a leading distributor headquartered in Arlington Texas USA and a top supplier to the industrial and agricultural sectors https://www.telecheminternational.com g. 7-6-18: Arrayit accounting department reports $9,000 specialty chemical sales payment from chemical trading subsidiary TeleChem International to a leading specialty chemical provider headquartered in Arlington Texas USA and serving the robust construction markethttps://www.telecheminternational.comc h. 10-10-18: Arrayit shipping department ships $5,800 specialty chemical sale for chemical-trading subsidiary TeleChem International to Science Applications International Corporation SAIC HQ Fairfield New Jersey USA and strategic supplier to the United States military http://www.saic.com i. 10-10-18: Arrayit shipping department ships $8,100 specialty chemical sale to a top chemical distribution leader headquartered in Arlington Texas USA and serving the massive and rapidly growing $470 billion industrial and agricultural specialty chemical markets https://www.telecheminternational.com j. 11-12-18: Arrayit accounting department reports $8,100 specialty chemical sales payment from a top chemical subsidiary TeleChem International customer headquartered in Arlington Texas USA and serving the massive $260 billion industrial and specialty chemical markets https://www.telecheminternational.com k. 11-15-18: Arrayit sales and marketing team reports $38,700 specialty chemicals purchase request from advanced aerospace leaders Altum Aerospace headquartered in Sunrise Florida USA and a premium supplier to the massive commercial aviation and US defense industries http://altumaerospace.com l. 12-11-18: Arrayit accounting department reports $5,800 TeleChem International specialty chemical sales payment from top government contractor SAIC headquartered in Reston Virginia USA and providing key intelligence to United States Army, Navy, Air Force and Marines http://www.saic.com m. 12-11-18: Arrayit government contracts team reports $41,600 specialty chemical sales request from top government contractor DLA Troop Support HQ in Philadelphia Pennsylvania USA and providing combat support to the $574 billion United States Department of Defense http://www.dla.mil/TroopSupport.aspx … n. 3-15-19: Arrayit sales and marketing team reports $9,000 specialty chemical sale to a leading specialty chemical company headquartered in Arlington Texas USA and a key supplier to leading industrial manufacturers in the massive $700 billion+ US chemical industry https://www.telecheminternational.com o. 3-29-18: Arrayit government contracts sales team quotes $52,000 TeleChem International subsidiary specialty chemical sale to a top defense logistics supply leader headquartered in the Northeastern USA and serving the massive $686 billion United States military https://www.telecheminternational.com p. 4-24-19: Arrayit government contracts and chemical sales team from subsidiary TeleChem International reports $9,000 specialty chemical sale to a leading chemical company HQ in Arlington Texas USA and a key supplier to the massive $800 billion US chemical industry https://www.telecheminternational.com
21. Micro array services: a. 9-12-2016: Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider. https://twitter.com/arrayit/status/775361066666594304 b. 7-1-16: Arrayit signs $27.1 million term sheet for microarray services with US-based research leader http://arrayit.com/Services/services.htmlhttps://twitter.com/arrayit/status/748909205969514496 c. Arrayit microarray services team completes pilot project for top investigator at the world renowned cancer center Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology MIT in Cambridge Massachusetts USA ki.mit.edu d. From 1-3-18: Arrayit microarray services team quotes $2,500,000 research sale to top proteomics research laboratory headquartered in the Northeastern USA http://arrayit.com/Services/services.html e. 1-25-18: Arrayit schedules business-to-business B2B site visit today with a large microarray services account headquartered in the Eastern USA http://arrayit.com/Services/services.html … f. 9-5-18: Arrayit sales and marketing team reports $30,000 microarray life sciences services sale to a leading clinical medicine company headquartered in the Southeastern USA and commercializing finger stick testing products for the lucrative wellness test markets http://arrayit.com/Clinical/clinical.html … g. 9-11-18: Arrayit government contracts team submits $850,000 microarray service bid to a top government agency studying serum protein biomarkers as indicators of cardiovascular, neurological, metabolic, oncologic and inflammatory conditions in a large patient cohort http://arrayit.com/Clinical/clinical.html … h. 9-21-18: Arrayit CLIA clinical laboratory completes $77,000 microarray manufacturing run to build inventory for a top biotechnology customer headquartered in the Northeastern USA and focusing on the lucrative high-growth wellness and healthcare testing markets http://arrayit.com/Clinical/clinical.html …
22. Micro array platforms: a. Arrayit completes site visit with major European life sciences leader regarding sale of 40 microarray platforms arrayit.com/Products/produ… b. Arrayit patented and proprietary microarray platform featuring miniaturization, parallelism and automation is well-suited for Global In Vitro Diagnostic Market Boom including in vitro diagnostic IVD tests per top analysts Zacks finance.yahoo.com/news/global-vi… c. Arrayit microarray technology customers include 8 of the world's top 10 pharmaceutical companies with a combined market cap exceeding $1.4 trillion genengnews.com/the-lists/top-… d. Arrayit Store sales exceed $55,000,000 all time on 230,706 products and services sold since on-line inception shop.arrayit.com e. Arrayit proprietary DNA microarray platform well-positioned in the gene expression market which, according to business research leaders MarketsandMarkets™, is expected to reach $5.3 billion by 2020 https://www.marketsandmarkets.com/PressReleases/gene-expression-analysis.asp … f. 2-27-18: Arrayit sales and marketing team quotes $1,490,000 microarray platform to a top biomedical research laboratory headquartered in the Southern USA and specializing in the analysis of genomic and proteomic biomarkers http://arrayit.com/Microarray_Diagnostics/Diagnostic_Platforms/diagnostic_platforms.html … g. 2-17-18: Arrayit sales and marketing department quotes $100,700 microarray platform to a top researcher at complex diagnostics and precision medicine leading Bioceryx headquartered in Menlo Park California USA https://www.bioceryx.com h. 3-21-18: Arrayit sales and marketing team reports $109,500 microarray life sciences platform sale to molecular diagnostics leaders Bioceryx headquartered in Menlo Park California USA and making advances in precision medicine universally accessible to all patients https://www.bioceryx.com i. 4-20-18: Arrayit sales and marketing team reports $145,000 microarray life sciences platform request from top life science distributor Al Rayyan International headquartered in Amman Jordan and providing premium sales support in the expanding Middle East markets https://www.linkedin.com/in/wassan-al-saffar-617874105/#experience-section … j. 4-23-18: Arrayit sales and marketing team reports $51,800 microarray life sciences platform exclusive purchasing request from top life sciences distributors Intercovamex headquartered in Cuernavaca Morelos Mexico and serving the biotechnology growth markets http://www.intercovamex.com k. 4-25-18: Arrayit sales and marketing team provides system documentation information for a $168,000 microarray life sciences platform sale to a top biomedical distributor in the Middle East serving the rapidly expanding research, clinical and biotechnology markets http://arrayit.com/Products/Microarrayers/microarrayers.html … l. 5-14-18: Arrayit sales and marketing team completes on-site microarray life sciences platform training in New York City USA for top scientists at a leading cellular therapeutics company headquartered in the Middle East http://arrayit.com/Products/Microarray_Platforms/microarray_platforms.html … m. 5-14-18: Arrayit engineering team provides technical support regarding $80,000 life sciences platform sale to top life sciences distributor Al Rayyan International Scientific Company headquartered in Amman Jordan and expanding Middle East revenues and earnings http://arrayit.com/Products/products.html … n. 6-12-18: Arrayit sales and marketing team reports $138,000 microarray life sciences platform request from top distributor Al Rayyan International Scientific Company headquartered in Amman Jordan and serving the lucrative Middle East clinical testing markets https://www.facebook.com/Al-Rayyan-International-Scientific-Company-1959224747725660/ … o. 8-9-18: Arrayit sales and marketing team reports $42,000 microarray life sciences platform sales request from top life sciences distributor VF Productions headquartered in Selangor Malaysia and serving the high-growth biotechnology and consumer healthcare markets https://www.vfproductions.biz p. 9-24-18: Arrayit shipping department ships $44,000 microarray platform sale to a leading research and healthcare laboratory headquartered in the United States and applying emerging technology to improve and ensure the performance of commercial testing products http://arrayit.com/Clinical/clinical.html … q. 1-18-19: Arrayit sales and marketing team reports $103,000 microarray life sciences platform sales tender from a top distributor headquartered in the Middle East and serving the lucrative high-growth research and Middle Eastern consumer lifestyle testing markets http://arrayit.com/Products/Microarray_Platforms/microarray_platforms.html … r. 1-29-19: Arrayit sales and marketing team reports $29,400 microarray life sciences platform sales request from a biotechnology leader HQ in the European Union and serving the lucrative high-growth global biomedical research and consumer lifestyle testing markets http://arrayit.com/Products/Microarray_Platforms/microarray_platforms.html … s. 3-12-19: Arrayit sales and marketing team reports $280,000 life sciences platform sales request from $209.4 billion pharmaceutical giant Novartis NYSE:NVS headquartered in Basel Switzerland and serving customers worldwide with premium consumer healthcare products https://www.novartis.com t. 3-19-19: Arrayit shipping department reports $29,900 expedited microarray life sciences platform sales shipping request from a leading biotech company HQ in the European Union and commercializing products for the massive global health and wellness testing markets http://arrayit.com/Products/Microarray_Platforms/microarray_platforms.html … u. 4-11-19: Arrayit sales and marketing team reports $135,000 microarray life sciences platform sales request from a leading healthcare company HQ in Quito Ecuador and serving the lucrative high-growth South America healthcare and consumer lifestyle testing markets http://arrayit.com/Products/Microarray_Platforms/microarray_platforms.html … v. 5-16-19: Arrayit sales and marketing team reports $138,500 microarray life sciences platform sales request from a top healthcare distributor headquartered in Quito Ecuador and serving the lucrative high-growth South American medical research and healthcare markets https://www.bmbio.com w. 5-16-19: Arrayit sales and marketing team reports $27,000 microarray life sciences platform sales request from top distributor BM Equipment headquartered in Tokyo Japan and serving the massive biomedical research and consumer lifestyle testing markets in Japan https://www.bmbio.com x. 6-3-19: Arrayit sales and marketing team reports $240,000 microarray life sciences platform sales request from the prestigious Vinaquips JSC Company HQ in Hanoi Vietnam and serving the rapidly expanding Vietnam research and consumer lifestyle testing markets http://vinaquips.com y. 7-12-19: Arrayit sales and marketing team reports $100,000 microarray life science platform request from a top veterinarian at the prestigious Laboratory of Veterinary Epidemiology headquartered in Warsaw Poland and advancing the forefronts of veterinary healthcare http://wmw.sggw.pl/en/departments/laboratory-of-veterinary-epidemiology-and-economics/ …
RECENT Press Releases and important TWEETS: 1-3-18 Arrayit advanced microarray technology to be incorporated into a clinical trial by a major pharmaceutical giant in a development that could significantly increase revenues and earnings in 2018 http://arrayit.com/Products/products.html … 5-19-18: Sunnyvale, May 09, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces receipt of a new clinical licensure from the Centers for Medicare and Medicaid Services (CMS), which oversees the Clinical Laboratory Improvement Amendments (CLIA) Program. Arrayit's new CLIA license, issued in conjunction with the Department of Health and Human Services (HHS) and the California Department of Public Health (CDPH), provides certification for its Silicon Valley clinical laboratory. https://www.marketwatch.com/story/arrayit-corporation-announces-new-clinical-licensure-from-the-centers-for-medicare-and-medicaid-services-2018-05-09?siteid=bigcharts&dist=bigcharts
5-30-18: Sunnyvale, CA , May 30, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has achieved the clinical testing accuracy required for reimbursement under Medicare and Medicaid. Accuracy testing, supervised by the College of American Pathologists (CAP), assesses quantitative measurements of the immunoglobulin E (IgE) regulated analyte in the general immunology proficiency testing program. Arrayit’s testing performance included a score of 100% on the SA-2018 proficiency event and constituted successful cumulative performance required by the Centers for Medicare and Medicaid Services (CMS) over a one-year testing period. CMS regulates approximately 260,000 clinical laboratories through the Clinical Laboratory Improvement Amendments (CLIA) program, and proper certification is required to receive Medicare and Medicaid payments. https://www.marketwatch.com/story/arrayit-corporation-achieves-testing-accuracy-required-for-medicare-and-medicaid-reimbursement-2018-05-30?siteid=bigcharts&dist=bigcharts
6-18-18: June 18, 2018 - Sunnyvale, CA - Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has engaged a nationwide network of professional sales representatives ("sales reps") to sell and distribute the company's allergy tests across the Continental United States, with focus areas in the Pacific Northwest, West, Southwest, Rocky Mountain, Midwest, Northeast and Southeast regions. The network comprises 1,700 sales professionals including 500 sales reps with specific training in finger stick sampling, blood card collection and microarray technology. This extensive professional network will be used to enroll hospitals, health maintenance organizations (HMOs), doctor's and dentist's offices, health clinics and retail stores into the allergy-testing program. https://www.marketwatch.com/story/arrayit-corporation-announces-nationwide-allergy-testing-sales-and-distribution-network-2018-06-18?siteid=bigcharts&dist=bigcharts
6-29-18: Arrayit signs capital financing agreement with a top buy-side analyst at a leading corporate intelligence firm headquartered in London UK with offices in New York and providing buy-side intelligence to high net worth retail investors, institutional investors and hedge funds. https://twitter.com/arrayit/status/1012723616373280768
7-2-18: Sunnyvale, July 02, 2018 (GLOBE NEWSWIRE) -- July 2, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has completed an allergy testing pilot program for one of nation’s largest chains of retail stores. The retailer collected finger stick blood specimens from 126 customers at their in-store clinics, and shipped the blood cards to Arrayit for processing. Arrayit processed the specimens and reported 126 quantitative total immunoglobulin E (IgE) measurements and 15,120 allergen-specific determinations indicative of food and environmental allergies. The test results were reviewed and approved by the retail chain’s Chief Medical Officer. https://www.marketwatch.com/story/arrayit-corporation-completes-allergy-testing-pilot-program-for-one-of-the-nations-largest-retail-chains-2018-07-02?siteid=bigcharts&dist=bigcharts
7-3-18: Arrayit senior management receives NASDAQ and NYSE up-listing proposal from small and mid-cap consulting experts http://uplisting.com focusing on growth companies seeking to improve and enhance shareholder value by listing on a major stock exchange http://www.uplisting.com https://twitter.com/arrayit/status/1014187818891935744 7-3-18: Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval. https://twitter.com/arrayit/status/1014171600051007488 7-8-18: Arrayit web design team updates investor main page and 33 sub-pages including updated information and links regarding Arrayit technology, auditors, biochemistry 101, celebrity spokesperson, CEO, SEC filings, XBRL filings and many other ARYC investor topics http://arrayit.com/Microarray_Investor/microarray_investor.html … https://twitter.com/arrayit/status/1016023938470576128 7-16-18: July 16, 2018 - Sunnyvale, CA - Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces the sale of clinical instrumentation to the United States Food and Drug Administration (FDA). Arrayit uses the same clinical instrumentation in its Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the Centers for Medicare and Medicaid Services (CMS) and the State of California Department of Public Health (CDPH). The instrumentation reads and reports test results for the company's allergy and dietary wellness tests and pipeline tests for ovarian cancer and Parkinson's Disease (PD). https://www.marketwatch.com/press-release/arrayit-corporation-reports-clinical-instrumentation-sale-to-the-united-states-food-and-drug-administration-2018-07-16?siteid=bigcharts&dist=bigcharts
7-25-18: Arrayit senior management completes analyst call with top buy side analyst at the prestigious Alpha Deal Group headquartered in New York NY USA and providing premium independent due diligence for high net-worth retail, instituional and hedge fund customers (link: http://www.alphadealgroup.com) alphadealgroup.com https://twitter.com/arrayit/status/1022158461302267905
7-30-18: Sunnyvale, July 30, 2018 (GLOBE NEWSWIRE) -- July 30, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, signs allergy testing contracts with a consortium of medical clinics nationwide. The network comprises 178 medical clinics in 29 of the 48 contiguous United States including the Northeast, Southeast, Midwest, South, Southwest, Pacific and Pacific Northwest regions, with single clinics staffing up to 70 physicians. The clinics are using Arrayit allergy testing services to assist physicians in diagnosing and treating allergy and asthma across a wide range of medical specialties and focus areas including anti-aging, back pain and sciatica, chiropractic care, dermatology, digestive health, ear nose and throat (ENT), family medicine, gastroenterology, health and beauty, immunology, integrative medicine, internal medicine, obesity, obstetrics and gynecology (OB-GYN), pain relief, pediatrics, personalized medicine, preventative medicine, primary care, rehabilitation, sinus, spinal care, urgent care, weight loss, wellness and women’s health. Arrayit recently established a nationwide sales network of 1,700 sales professionals to sell and distribute the company’s finger stick microarray tests to medical clinics and retail chains, completed allergy pilot testing with one the nation’s largest chains of retail stores, met with top officials at the United States Food and Drug Administration (FDA) to discuss FDA approval of a major product line, and reported the sale of clinical instrumentation to the FDA. Arrayit microarray tests conveniently use a few drops of patient blood collected on a blood card to assist doctors in identifying and treating food intolerance, allergy and asthma, and pipeline indications for more serious conditions such as ovarian cancer and Parkinson’s Disease. Doctors can use allergy test results as quantitative tools to inform decisions regarding allergy medicines, immunotherapy, food elimination and lifestyle changes. https://www.marketwatch.com/press-release/arrayit-corporation-signs-allergy-testing-contracts-with-a-nationwide-consortium-of-medical-clinics-2018-07-30?siteid=bigcharts&dist=bigcharts
8-7-18: Arrayit senior management submits $5,000,000 strategic investment proposal to a companion diagnostics and therapeutics leader headquartered in the San Francisco Bay Area USA and commercializing medicines for the massive $45 billion neurodegenerative market https://twitter.com/arrayit/status/1026860386782339072
8-13-18: August 13, 2018 - Sunnyvale, CA - Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, has been approved for in-store allergy testing promotions by a major United States retailer. Arrayit sales and marketing experts will conduct allergy test promotions in-store, and medical professionals at in-store clinics will collect finger stick blood specimens. Two thousand retail locations nationwide averaging 3,000 customer visits per store per day would give Arrayit access to 6 million retail customers daily, creating the potential for exponential sales growth. This promotional campaign required rigorous vetting and high-level corporate approval by the retailer, which reports revenues exceeding $50 billion annually.
8-27-18: August 27, 2018 - Sunnyvale, CA - Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces allergy testing partnerships with multiple providers of allergen immunotherapy products including sub-cutaneous, sublingual, and oral allergy medicines designed to treat patients of allergy and asthma. Allergen immunotherapy, a time-tested clinical approach, can reduce or eliminate allergy and asthma symptoms by lowering the levels of specific cellular proteins known as immunoglobulin E (IgE) molecules that activate the immune system and trigger immune responses. Through these partnerships, doctors prescribing Arrayit allergy tests gain access to a portfolio of safe, effective and convenient allergy medicines for their allergy and asthma patients, including custom immunotherapy products formulated upon review of quantitative allergy test results. https://www.marketwatch.com/press-release/arrayit-corporation-announces-allergy-testing-partnerships-with-major-allergy-therapeutics-providers-2018-08-27-51843016?siteid=bigcharts&dist=bigcharts
9-10-18: September 10, 2018 - Sunnyvale, CA - Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that Arrayit's proprietary finger stick allergy microarray test has been approved for direct Medicare billing by the Centers for Medicare and Medicaid Services (CMS). The Medicare national health insurance program provides health insurance to more than 55 million Americans annually, including 46 million seniors and 9 million younger people. CMS projects a 2018 Medicare budget of approximately $705,000,000,000 ($705 billion dollars), representing about 17% of total federal spending. https://www.marketwatch.com/press-release/arrayit-corporation-approved-for-direct-medicare-billing-by-the-centers-for-medicare-and-medicaid-services-2018-09-10?siteid=bigcharts&dist=bigcharts
9-24-18: Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports the shipment of clinical instrumentation and quantification software to the United States Food and Drug Administration (FDA). Arrayit uses the same instrumentation and software to test for allergy and food intolerance as well as pipeline indications for ovarian cancer and Parkinson's Disease (PD). Testing is performed in the company's Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the California Department of Public Health (CDPH) and the Center for Medicare and Medicaid Services (CMS). https://www.marketwatch.com/press-release/arrayit-corporation-ships-clinical-instrumentation-and-software-to-the-united-states-food-and-drug-administration-2018-09-24?siteid=bigcharts&dist=bigcharts
10-8-18: Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports that its clinical team aced three consecutive rounds of blinded-specimen Proficiency Testing (PT) with the College of American Pathologists (CAP). The SC-2017, SA-2018 and SB-2018 triannual CAP Diagnostic Immunology Surveys require highly quantitative measurements of immunoglobulin E (IgE), the antibody molecules measured by the company's finger stick allergy microarray tests. Arrayit's highly accurate PT performance showcases the robustness of the company's proprietary allergy testing platform and reagents, which are increasingly being leveraged by doctors as a tool to diagnose and treat allergy and asthma. https://www.marketwatch.com/press-release/arrayit-corporation-aces-three-consecutive-rounds-of-proficiency-testing-with-the-college-of-american-pathologists-2018-10-08?siteid=bigcharts&dist=bigcharts
10-22-18: Published: Oct 22, 2018 5:30 a.m. ET Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, launches a fully automated allergy testing portal for doctors and clinics to streamline and accelerate the allergy testing and treatment process. The Patient Data Solutions (PDS) allergy-testing suite is secure and fully compliant with Health Insurance Portability and Accountability Act (HIPAA) requirements to ensure the privacy of patient health records. The new PDS portal allows doctors to order allergy blood card collection kits, request express mail shipping labels, download allergy test results, and order immunotherapy products from our independent allergy therapeutics partners. The PDS portal, which is free of charge to doctors and clinics, offers continuous, real-time technical assistance to ensure a positive on-line experience. https://www.marketwatch.com/press-release/arrayit-corporation-launches-patient-data-solutions-allergy-testing-portal-for-doctors-and-clinics-2018-10-22?siteid=bigcharts&dist=bigcharts
10-31-18: Arrayit provides an update to shareholders. We are currently is a quiet period regarding our financials. Our next financial announcement will be the filing of our 10-K and 10-Q forms through 2018. Thanks everyone for your continued support and patience! http://arrayit.com/index.html https://twitter.com/arrayit/status/1057654833040113665
11-5-18: Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces expansion of its proprietary finger stick microarray allergy testing platform to a growing number of major market brands. Highly automated Arrayit technology is inherently suited to leveraging multiple brands and their unique venues and relationships to reach a larger number of allergy patients more quickly. Each brand serving major retail chains, large government agencies, medical clinics and doctor offices receive the same high-level testing support and treatment options through the company's Patient Data Solutions (PDS) on-line allergy testing portal and therapeutics affiliates.
11-19-18: Sunnyvale, Nov 19, 2018 (GLOBE NEWSWIRE via COMTEX) -- Sunnyvale, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces an allergy testing agreement with Northern California healthcare leader Sutter Health. The company is providing its proprietary microarray-based finger stick allergy testing services to Sutter Health via doctors in the Sutter Health-affiliated Palo Alto Medical Foundation. Sutter Health, one of the nation's largest healthcare networks, is headquartered in Sacramento California and has 50,000 employees including 12,000 physicians and 14,000 nurses serving 3 million Northern California patients. Sutter Health draws 19% of its revenue from the California Medical Assistance Program (Medi-Cal) and reports total patient service revenues of $12,000,000,000 ($12 billion) annually. https://www.marketwatch.com/press-release/arrayit-corporation-announces-allergy-testing-agreement-with-sutter-health-2018-11-19?siteid=bigcharts&dist=bigcharts
12-3-18: Sunnyvale, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces a new allergy testing services agreement with a major healthcare company specializing in patient health and wellness. Arrayit offers simple non-invasive testing services that measure reactivity of immunoglobulin E (IgE) antibodies to an extensive panel of food, environmental and specialty allergens as a precision healthcare solution to assist physicians in the diagnosis and treatment of allergy and asthma. The healthcare leader provides health and pharmacy services to more than 10 million retail, commercial and corporate customers and reports revenues exceeding $35,000,000,000 ($35 billion dollars) annually. https://www.marketwatch.com/press-release/arrayit-corporation-announces-allergy-testing-services-agreement-with-a-major-health-and-wellness-provider-2018-12-03?siteid=bigcharts&dist=bigcharts
12-17-18: Sunnyvale, Dec 17, 2018 (GLOBE NEWSWIRE via COMTEX) -- Sunnyvale, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports fulfillment of a clinical instrumentation contract with the United States Food and Drug Administration (FDA), which involves an exacting series of contractual steps including receiving the solicitation, placing the bid, winning the award, receiving the purchase order, shipping the system, gaining an installation and acceptance notice, and reporting FDA approval of payment for fulfillment of the contract. The clinical instrumentation in the FDA contract is the same technology deployed by Arrayit in its Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the Centers for Medicare and Medicaid Services (CMS) and the State of California Department of Public Health (CDPH) for allergy and dietary wellness testing and pipeline tests for ovarian cancer and Parkinson's Disease (PD). https://www.marketwatch.com/press-release/arrayit-corporation-fulfills-clinical-instrumentation-contract-with-the-united-states-food-and-drug-administration-2018-12-17-51843025?siteid=bigcharts&dist=bigcharts 12-26-18: Arrayit business development team completes conference call with a leading healthcare focused venture capital firm headquartered in New York NY USA and seeking partnering opportunities in the lucrative high-growth US health and wellness testing markets http://arrayit.com/Clinical/clinical.html … https://twitter.com/arrayit/status/1077980929417654272 12-31-18: Dec 31, 2018 (GLOBE NEWSWIRE via COMTEX) -- Sunnyvale, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces a letter to shareholders from Arrayit Chief Executive Officer Rene Schena. The letter is downloadable at this link: http://www.arrayit.com/confidential/Letter-to-Arrayit-Shareholders.pdf At year end, we implemented a new electronic medical billing solution and we expect to bill $1 million per week for our health and wellness tests. The actual contribution of medical reimbursement to our revenues and earnings will be detailed in financial reports, which we anticipate filing in the coming quarter. 1-10-18: Arrayit financial team completes 2018 inventory observation site visit this week at our Silicon Valley California USA headquarters with Prime Global independent auditing firm Rosenberg Rich Baker Berman & Company RRBB headquartered Somerset New Jersey USA http://www.rrbb.com 1-14-19: Sunnyvale, Jan 14, 2019 (GLOBE NEWSWIRE via COMTEX) -- Sunnyvale, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports that its clinical team has aced four consecutive rounds of proficiency testing (PT) with a nationally recognized proficiency testing leader. Proficiency testing requires precise quantification of specific cellular immunoglobulin E (IgE) antibodies, the protein biomarkers often associated with allergy and asthma. PT samples are blind-tested for IgE concentration as a means of evaluating the accuracy of a clinical test. Arrayit's clinical team aced four consecutive rounds of PT over a 12-month period, indicating that its microarray testing technology is highly accurate when assessed by an independent third party. https://www.marketwatch.com/press-release/arrayit-corporation-aces-fourth-consecutive-round-of-proficiency-testing-with-a-top-proficiency-testing-company-2019-01-14-5184301?siteid=bigcharts&dist=bigcharts 1-28-19: Sunnyvale, Jan 28, 2019 (GLOBE NEWSWIRE via COMTEX) -- Sunnyvale, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports that its proprietary microarray-based finger stick allergy testing services are endorsed by prestigious health and wellness leader First Pediatrics Medical Group. Headquartered in Fresno, California USA https://www.marketwatch.com/press-release/arrayit-corporation-allergy-testing-services-endorsed-by-leading-pediatrics-medical-group-2019-01-28?siteid=bigcharts&dist=bigcharts 2-6-19: Arrayit production team commences $96,000 microarray manufacturing run to build inventory for a top account HQ in the United States and commercializing proprietary finger stick microarray tests for the lucrative high-growth health and wellness markets http://arrayit.com/Clinical/clinical.html … 2-11-19: Sunnyvale, Feb 11, 2019 (GLOBE NEWSWIRE via COMTEX) -- Sunnyvale, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports that its nationwide allergy testing consortium has more than doubled in the past six months to 410 medical clinics. The rapidly expanding network using the company's powerful finger stick allergy testing services comprises… https://www.marketwatch.com/press-release/arrayit-corporation-nationwide-allergy-testing-network-doubles-to-more-than-400-healthcare-clinics-2019-02-11-51842952?siteid=bigcharts&dist=bigcharts 2-25-19: Sunnyvale, Feb 25, 2019 (GLOBE NEWSWIRE via COMTEX) -- Sunnyvale, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that its physician-prescribed finger stick allergy testing services are now available in-network from a leading commercial health insurance company. https://www.marketwatch.com/press-release/arrayit-corporation-announces-in-network-allergy-testing-services-contract-with-a-top-five-commercial-healthcare-benefits-company-2019-02-25-6184153?siteid=bigcharts&dist=bigcharts 3-11-19: Sunnyvale, March 11, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, increases weekly guidance for medical billing associated with its physician-prescribed allergy testing services from $1,000,000 ($1 million) per week as presented in the December 31 2018 CEO Letter to Shareholders, to $2,000,000 ($2 million) per week effective immediately. The 100% weekly guidance increase from $1 million to $2 million per week for fiscal year 2019 (FY2019) is based on medical billing growth during the first quarter of FY2019, the number of new clinics being added to our Patient Data Solutions portal, and the rate of allergy testing services adoption in the marketplace. https://www.marketwatch.com/press-release/arrayit-corporation-increases-weekly-guidance-for-doctor-prescribed-allergy-testing-clinical-services-2019-03-11-61844929?siteid=bigcharts&dist=bigcharts 3-19-19: Arrayit senior management receives senior exchange listing information from up-listing experts http://Uplisting.com headquartered in New York NY USA and facilitating NASDAQ listings by maximizing public company business goals and shareholder value http://www.uplisting.com https://twitter.com/arrayit/status/1108083028260052992 3-26-19: Sunnyvale, March 25, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, is working closely with an Apple enterprise healthcare partner to increase revenues and earnings for fiscal year 2019 (FY2019). This new partnership leverages the widely used Apple iPad platform and iPhone operating system (iOS) to streamline key aspects of Arrayit doctor-prescribed allergy testing services including patient scheduling, test kit ordering, electronic retrieval of test results and requests for ancillary treatment options, all in manner this is fully compliant with the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Arrayit's convenient finger stick testing services are being increasingly utilized by doctors to detect, manage and treat allergy and asthma, which impact approximately 60 million Americans annually. https://www.marketwatch.com/press-release/arrayit-corporation-appoints-apple-enterprise-healthcare-partner-to-accelerate-fy2019-revenues-and-earnings-growth-2019-03-25-51843036?siteid=bigcharts&dist=bigcharts 3-28-19: Arrayit clinical sales team reports $2,000,000 clinical testing services sales to leading health benefits payers providing premium government and commercial healthcare coverage to 100 million+ Americans in the massive $3 trillion US healthcare markets http://arrayit.com/Clinical/Allergy_Test/allergy_test.html … https://twitter.com/arrayit/status/1111304057337962497 3-31-19: Financials Update #32-35 - consecutive tweets: Our financial team has considered of all the issues related to our financials, particularly those involving our new clinical testing services segment, and has concluded that additional time is needed to file our financial reports http://www.arrayit.com Our goal regarding our financial statements is to file audited financials for fiscal years 2014-2018 (FY2014-2018) and the first quarter of 2019 (Q1-2019) as quickly as possible upon receipt of all of the required documentation http://www.arrayit.com It is important to emphasize that issues related to new medical billing involve complex contributions of commercial and government payers, and correct accounting has enormous implications for revenues and earnings ongoing forward http://www.arrayit.com Arrayit is fully committed to its shareholders, to filing its financial reports as quickly as possible, to listing on a national exchange as soon as possible and to accelerating growth through deployment of our new healthcare products http://www.arrayit.com https://twitter.com/arrayit/status/1112552064607875072 4-2-19: Arrayit senior management receives major exchange up-listing proposal from a leading corporate consulting and advisory firm headquartered in Connecticut USA and providing strategic advice to public companies during the national exchange listing process http://arrayit.com https://twitter.com/arrayit/status/1113164233515065344 4-8-19: Sunnyvale, April 08, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that its proprietary finger stick allergy testing services continue to be evaluated for physician-ordered sale by a major pharmacy retail chain. Arrayit allergy testing services empower doctors to more accurately diagnose and treat allergy and asthma using a few drops of patient blood. The speed and simplicity of the test results, coupled with powerful and secure Apple enterprise healthcare resources, afford on-site test reporting and ancillary health services including custom doctor-prescribed immunotherapy options through the company’s therapeutics partners. This US-based pharmacy retailer operates an extensive national network of pharmacies and healthcare clinics, and reports annual revenues topping $100,000,000,000 ($100 billion). http://www.globenewswire.com/news-release/2019/04/08/1798827/0/en/Arrayit-Corporation-Announces-Allergy-Testing-Services-Evaluation-Expansion-by-a-Major-Pharmacy-Retailer.html
News 
Market Data 
Discover 
AI
